AGAPE ATP CORPORATION Operating Lease, Payments
AGAPE ATP CORPORATION (ATPC) reported Operating Lease, Payments of $23.62 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-14
- AGAPE ATP CORPORATION operating lease, payments for the quarter ending 2026-06-30 was -$3.08K.
- AGAPE ATP CORPORATION operating lease, payments for the quarter ending 2026-03-31 was $26.69K, a 0.00% change year-over-year.
- AGAPE ATP CORPORATION operating lease, payments for the quarter ending 2025-12-31 was -$21.65K.
- AGAPE ATP CORPORATION operating lease, payments for the quarter ending 2025-09-30 was $83.21K, a 72.44% increase year-over-year.
- AGAPE ATP CORPORATION operating lease, payments for fiscal 2025 was $65.99K, a 43.52% increase from fiscal 2024.
- AGAPE ATP CORPORATION operating lease, payments for fiscal 2024 was $45.98K, a 13.04% increase from fiscal 2023.
- AGAPE ATP CORPORATION operating lease, payments for fiscal 2023 was $40.67K, a 7073.72% increase from fiscal 2022.
- AGAPE ATP CORPORATION operating lease, payments for fiscal 2022 was $567.00.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $23.62K 10-Q · filed 2026-08-14 | $1.97K derived: sum of 3 quarters · filed 2026-08-14 | $85.18K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $26.69K 10-Q · filed 2026-05-15 | $5.04K derived: sum of 2 quarters · filed 2026-05-15 | $88.25K derived: sum of 3 quarters · filed 2026-05-15 | $65.99K derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | -$21.65K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | $61.56K derived: sum of 2 quarters · filed 2026-04-13 | $39.30K derived: sum of 3 quarters · filed 2026-04-13 | $65.99K 10-K · filed 2026-04-13 |
| 2025-09-30 | $83.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $60.94K derived: sum of 2 quarters · filed 2025-11-13 | $87.63K 10-Q · filed 2025-11-13 | $67.58K derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | -$22.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $4.42K 10-Q · filed 2025-08-13 | -$15.62K derived: sum of 3 quarters · filed 2025-08-13 | $32.63K derived: sum of 4 quarters · filed 2025-08-13 |
| 2025-03-31 | $26.69K 10-Q · filed 2025-05-15 | $6.64K derived: sum of 2 quarters · filed 2025-05-15 | $54.90K derived: sum of 3 quarters · filed 2025-05-15 | $44.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | -$20.05K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $28.21K derived: sum of 2 quarters · filed 2025-03-31 | $17.30K derived: sum of 3 quarters · filed 2025-03-31 | $45.98K 10-K · filed 2025-03-31 |
| 2024-09-30 | $48.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $37.35K derived: sum of 2 quarters · filed 2024-11-14 | $66.03K 10-Q · filed 2024-11-14 | $96.64K derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-06-30 | -$10.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $17.77K 10-Q · filed 2024-08-14 | $48.39K derived: sum of 3 quarters · filed 2024-08-14 | $42.43K derived: sum of 4 quarters · filed 2024-08-14 |
| 2024-03-31 | $28.67K 10-Q · filed 2024-05-14 | $59.29K derived: sum of 2 quarters · filed 2024-05-14 | $53.33K derived: sum of 3 quarters · filed 2024-05-14 | $41.10K derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-12-31 | $30.62K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $24.66K derived: sum of 2 quarters · filed 2024-04-01 | $12.43K derived: sum of 3 quarters · filed 2024-04-01 | $40.67K 10-K · filed 2024-04-01 |
| 2023-09-30 | -$5.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$18.18K derived: sum of 2 quarters · filed 2023-11-14 | $10.06K 10-Q · filed 2023-11-14 | $3.29K derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | -$12.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $16.02K 10-Q · filed 2023-08-14 | $9.26K derived: sum of 3 quarters · filed 2023-08-14 | $5.17K derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | $28.24K 10-Q · filed 2023-05-15 | $21.48K derived: sum of 2 quarters · filed 2023-05-15 | $17.39K derived: sum of 3 quarters · filed 2023-05-15 | $9.59K derived: sum of 4 quarters · filed 2023-05-15 |
| 2022-12-31 | -$6.76K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$10.85K derived: sum of 2 quarters · filed 2023-03-31 | -$18.65K derived: sum of 3 quarters · filed 2023-03-31 | $567.00 10-K · filed 2023-03-31 |
| 2022-09-30 | -$4.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$11.89K derived: sum of 2 quarters · filed 2022-11-14 | $7.33K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$7.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $11.42K 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | $19.22K 10-Q · filed 2022-05-13 | |||
| 2021-03-31 | $3.91K 10-Q · filed 2021-05-17 | $745.00 derived: sum of 2 quarters · filed 2021-05-17 | -$59.00 derived: sum of 3 quarters · filed 2021-05-17 | |
| 2020-12-31 | -$3.16K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$3.97K derived: sum of 2 quarters · filed 2021-03-31 | $4.65K 10-K · filed 2021-03-31 | |
| 2020-09-30 | -$804.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $7.82K 10-Q · filed 2020-11-16 | ||
| 2020-06-30 | $8.62K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |